X You are viewing the latest eNews for Respiratory Care Professionals, our weekly email newsletter sent to thousands of professionals and students.

[Return Home]
[Subscribe for Free]
[Become a Sponsor]



NEWS-Line - eNews

FEATURED SPONSOR:

Desoto Memorial Hospital
Respiratory Therapist (RRT or CRRT)

Arcadia Florida


SPONSORS:

Blue Ridge Healthcare - Grace Hospital
Registered Respiratory Therapist

North Carolina

Job Board
Find a Job Near You

Nationwide

Sign In / Sign Up

Jobs RSS Feed

Your Weekly eNews from NEWS-Line.

Please "Like" NEWS-Line on Facebook and follow us on Twitter, Pinterest, and Linkedin.  Bookmark www.news-line.com to read all of the latest healthcare news that is posted daily.

Also, the April issue of NEWS-Line is available to read on your computer or electronic device. And remember . . . you can take NEWS-Line everywhere with you! Just save www.NEWS-Line.com to your phone for the latest news, jobs, education and blogs!

 



NEWS:

Know What Resources Help Protect Against Asthma Attack

If you suffer from asthma, you may think you’re “on your own” when it comes to figuring out how to control symptoms and triggers. You might not realize there are resources and information available to help you navigate the tough road of asthma.

May is Asthma and Allergy Awareness Month,” says allergist Stephen Tilles, MD, president of the American College of Allergy, Asthma and Immunology (ACAAI). “It’s an opportunity to make people aware of useful tools to help control asthma. One of the goals of asthma treatment is to have a normal, healthy lifestyle that includes exercise. Allergists are specially trained to work with patients to reach goals that help them breath better and create healthier lifestyles.”

Following is information ACAAI wants you to be aware of as you work towards controlling your asthma:

Biologics: the new frontier in asthma – Some people who suffer from severe asthm

Read Full Article

Join the NEWS-Line Blog Squad!

Study: Can Wrist Devices Detect Sleep Apnea With Lab Precision?

Researchers from the Peter O’Donnell Jr. Brain Institute will participate in a national study to determine whether medical devices used in the home can diagnose sleep apnea that often develops after traumatic brain injuries (TBI).

The $2.68 million study will compare the accuracy of formal laboratory screening versus wristwatch-like sensors that TBI patients will wear to measure sleep patterns.

Researchers want to know if wrist actigraphs, if proven comparable to full-scale polysomnography commonly used in sleep labs, would offer a reliable, accessible method to diagnose sleep apnea and lead to earlier treatment. The disorder – characterized by snoring and pauses in breathing that disrupt rest – often goes undiagnosed, which for TBI patients can be a crucial setback in recovery.

“Optimizing sleep is essential for neurorecovery after TBI,” said Dr. Kathleen Bell, the project’s investig

Read Full Article

New Imaging Technique Shows Effectiveness Of Cystic Fibrosis Drug

According to the Cystic Fibrosis Foundation, more than 30,000 Americans are living with the disorder. It currently has no cure, though a drug approved by the Food and Drug Administration treats the underlying cause of the disease. However, the drug’s effectiveness for each individual is unknown. Researchers from the University of Missouri School of Medicine have developed an imaging technique using a specific form of helium to measure the drug’s effectiveness. Researchers hope the finding could lead to improved therapies for cystic fibrosis and other lung conditions.

“People with cystic fibrosis have an imbalance of salt in their bodies caused by the defective CFTR protein,” said Talissa Altes, MD, chair of the Department of Radiology at the MU School of Medicine and lead author of the study. “The drug ‘ivacaftor’ targets this defective protein, but to what extent it is successful is n

Read Full Article

Study Launched To Better Understand Real-World Impact And Progression Of COPD

Duke University’s MURDOCK Study, the Duke Clinical Research Institute (DCRI) and Boehringer Ingelheim Pharmaceuticals Inc. announced today the launch of a new collaborative research effort to closely follow 850 people living with chronic obstructive pulmonary disease (COPD). The study will measure changes to participants’ health to better understand how COPD progresses within a community and follow participants for five years.

The MURDOCK COPD Study is an observational study that could help researchers develop a better way for healthcare providers to assess COPD progression in their patients. It could also provide new insights into the correlation between lung function, exercise capacity or COPD symptoms and disease progression.

COPD is a term that includes chronic bronchitis and/or emphysema. This disease can make breathing harder because less air flows in and out of the lungs. Chroni

Read Full Article

More News


LINKS:




UPCOMING EVENTS:

FSRC 2017 Space Coast Cardiopulmonary Conference

04/20/2017 - 04/21/2017
Florida Society for Respiratory Care

Congress 2017

10/04/2017 - 10/07/2017
AARC


Would you like to be Featured
in NEWS-Line for
Respiratory Care Professionals?

Click Here